Multicenter, phase I/II trial of anastrozole,palbociclib, trastuzumab, and pertuzumab in HR-positive,HER2-positive metastatic breast cancer

Category Primary study
JournalCancer Research
Year 2020
This article has no abstract
Epistemonikos ID: b2b8ea95cd361db800599ba8b2d086c67b655585
First added on: Feb 12, 2025